|
|
“The fact that Antibiotice invests in education and is the main partner of a medical event that brings together the elite of international cardiovascular surgery professionals, shows respect for knowledge and understanding the importance of this phenomenon in the training of physicians. By investing in education, Antibiotice provides very good prospects in the future, “said Prof. Igor Mokryk, cardiovascular surgeon at the Kiev Institute of the Heart. Some of the specialists who participated in the EABM 2017 scientific program visited Antibiotice. “We visited all plants/buildings, this was the first visit of a Romanian pharmaceutical company and there is no difference from the plants visited by now, on the contrary, our entire team has found that Antibiotice is at a much higher level than many of the plants we visited so far. Some of the company’s products recently registered in Serbia are part of the cardio-medical portfolio we use and we consider these medicines reliable “, said Dr. Alexandru Stancovici, cardiologist at Lescovat Hospital, Serbia. The pharmaceutical market is today a global market, and the products of a pharmaceutical company can circulate all over the world after obtaining the marketing authorization in their respective territories. Medical pathology is common in various international territories, and the EABM 2017 Congress has shown that therapeutic solutions, much like the medication used in Europe and Asia for various cardiovascular diseases or infections, are similar.
|
